TDM-optimized Teicoplanin Dosing Versus Standard of Care

PHASE4RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions

Bacterial Infections

Interventions

DRUG

Teicoplanin

Dose will be adjusted in the study arm using MIPD guided TDM- dosing

Trial Locations (1)

RECRUITING

RadboudUMC, Nijmegen

All Listed Sponsors

collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

Radboud University Medical Center

OTHER